Aurobindo Pharma Ltd has surged about 30% over the past 3 months, hitting a new record high. The momentum continued into August. Experts recommend short- to medium-term traders consider buying the stock with a target of Rs 1,580 in the next 3-4 weeks. The stock rose from Rs 1,124 on May 7, 2023, to Rs 1,465 on August 7, 2024, reflecting a 30% gain in just 3 months.
